English
norskPrimary health care: comparing public health nursing models in Ireland and Norway
Permanent lenke
https://hdl.handle.net/10037/6077
Dato
2013Type
Journal articleTidsskriftartikkel
Peer reviewed
Sammendrag
Health of populations is determined by amultitude of contextual factors. PrimaryHealth Care Reformendeavors to meet the broad
health needs of populations and remains on international health agendas. Public health nurses are key professionals in the delivery
of primary health care, and it is important for themto learn from global experiences. International collaboration is often facilitated
by academic exchanges. As a result of one such exchange, an international PHN collaboration took place.The aim of this paper is
to analyse the similarities and differences in public health nursing in Ireland and Norway within the context of primary care.
Forlag
Hindawi Publishing CorporationSitering
Nursing Research and Practice (2013), Article ID 426107Metadata
Vis full innførselSamlinger
Følgende lisensfil er knyttet til denne innførselen:
Relaterte innførsler
Viser innførsler relatert til tittel, forfatter og emneord.
-
Cochrane Collaboration Systematic Reviews may be based on trials not approved by a research ethics committee
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-10-27)Systematic reviews (SR) may potentially contain reports of primary trials with ethical problems. The Cochrane Collaboration SRs are considered as the highest standard in evidence-based health care resources. All SRs completed during the last 5 years (2013–2017) under the management of the Oral Health Group of the Cochrane Collaboration were identified. All primary trials included in the Oral Health ... -
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-07-29)1 Norum J, et al . ESMO Open 2017; 2 :e000222. doi:10.1136/esmoopen-2017-000222 Open Access Abstr A ct Background P embrolizumab is a new drug approved in several countries for second-line therapy in non-small cell lung cancer (NSCLC) being programmed cell death ligand (PD-L1) positive. This drug has a high cost, and the cost- effectiveness ratio has been debated. Patients ... -
The Use of eHealth and Provider-Based Health Services by Patients with Diabetes Mellitus: Protocol for a Cross-Sectional Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2016-10-31)<b>Background:</b> The prevalence of diabetes and the use of electronic health (eHealth) resources are increasing. People with diabetes need frequent monitoring and follow-up of health parameters, and eHealth services can be of great significance in this regard. However, little is known about the extent to which different kinds of eHealth tools are used, and how the use of eHealth is associated ...
